Meek David D.
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Meek David D.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| QURE | Sale | 2,112 | $14.45 | $30,518 | Jun 20, 2025 | |
| QURE | Award / Grant | 7,970 | — | — | Jun 11, 2025 | |
| QURE | Award / Grant | 8,080 | — | — | Jun 19, 2024 | |
| QURE | Sale | 2,229 | $5.12 | $11,412 | Jun 13, 2024 | |
| QURE | Sale | 2,290 | $18.85 | $43,167 | Jun 13, 2023 | |
| QURE | Sale | 389 | $19.71 | $7,667 | Feb 27, 2023 | |
| 0001576263 | Chief Executive Officer | Award / Grant | 89,379 | — | — | Jan 20, 2023 |
| 0001576263 | Chief Executive Officer | Sale | 3,179 | $42.38 | $134,726 | Jan 17, 2023 |
| 0001576263 | Chief Executive Officer | Sale | 4,616 | $40.41 | $186,533 | Dec 19, 2022 |
| 0001724344 | Disposition | 27,500 | $2.20 | $60,500 | Jul 7, 2022 | |
| QURE | Award / Grant | 9,080 | — | — | Jun 15, 2022 | |
| QURE | Sale | 602 | $16.70 | $10,053 | Feb 28, 2022 | |
| QURE | Award / Grant | 1,534 | — | — | Feb 24, 2022 | |
| 0001724344 | Award / Grant | 27,500 | — | — | Jan 18, 2022 | |
| 0001576263 | Chief Executive Officer | Award / Grant | 34,057 | — | — | Jan 14, 2022 |
| 0001724344 | Award / Grant | 22,000 | — | — | Apr 1, 2021 | |
| QURE | Sale | 505 | $37.50 | $18,938 | Mar 2, 2021 | |
| QURE | Award / Grant | 2,382 | — | — | Feb 25, 2021 | |
| QURE | Award / Grant | 2,063 | — | — | Feb 27, 2020 | |
| QURE | Sale | 718 | $62.20 | $44,660 | Jan 28, 2020 | |
| QURE | Award / Grant | 3,230 | — | — | Jan 25, 2019 | |
| 0001620546 | EVP and President, Oncology | Disposition | 51,640 | — | — | Jun 3, 2016 |
| 0001620546 | EVP and President, Oncology | Award / Grant | 27,976 | — | — | Mar 3, 2016 |
| 0001620546 | EVP and President, Oncology | Tax Withholding | 791 | $35.03 | $27,709 | Sep 2, 2015 |
| 0001620546 | EVP and President, Oncology | Other | 25,068 | — | — | Jul 1, 2015 |
| 0001235007 | Chief Commercial Officer | Award / Grant | 7,500 | — | — | Feb 6, 2014 |
| 0001235007 | Chief Commercial Officer | Option Exercise | 10,000 | $8.73 | $87,300 | Sep 12, 2013 |